TabletsTablets
Schedule H (Prescription Required)Glaucoma Drops & Pressure ReducersCode: 2727

Pilocarpine Tablets 5mg

Generic Formulation:Pilocarpine Tablets 5mg
Pack Size:10's

MRP Under Process

Official PMBI MRP is being updated for catalog code 2727.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Pilocarpine Hydrochloride (5 mg tablets) is an oral direct-acting muscarinic cholinergic agonist. It stimulates muscarinic M3 receptors on exocrine glands, dramatically stimulating salivary and lacrimal secretion. Indicated for the treatment of severe xerostomia (dry mouth) caused by radiotherapy for head and neck cancer, and dry mouth/eyes associated with Sjogren's syndrome.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2727.Report inaccuracy

Usage Guidelines

Take orally with a glass of water, three to four times daily with meals and at bedtime. Swallow whole. Maintain adequate hydration throughout the day.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Marked diaphoresis (excessive sweating in up to 30%), increased urinary frequency, nausea, flushing, chills, rhinitis, headache. Rare/Severe: Severe cholinergic toxicity, bradycardia, hypotension, and bronchospasm.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in uncontrolled asthma, acute iritis, and acute angle-closure glaucoma. Caution in cardiovascular disease and gallbladder/biliary disease.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or ophthalmic treatment recommendations. Always consult a registered ophthalmologist or ENT specialist before initiating, changing, or instilling any ophthalmic or otic medication.